AU2001276026A1 - B7-h2 molecules, novel members of the b7 family and uses thereof - Google Patents

B7-h2 molecules, novel members of the b7 family and uses thereof

Info

Publication number
AU2001276026A1
AU2001276026A1 AU2001276026A AU7602601A AU2001276026A1 AU 2001276026 A1 AU2001276026 A1 AU 2001276026A1 AU 2001276026 A AU2001276026 A AU 2001276026A AU 7602601 A AU7602601 A AU 7602601A AU 2001276026 A1 AU2001276026 A1 AU 2001276026A1
Authority
AU
Australia
Prior art keywords
family
molecules
novel members
novel
members
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001276026A
Inventor
Anthony J. Coyle
Christopher C Fraser
Stephen Manning
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Millennium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharmaceuticals Inc filed Critical Millennium Pharmaceuticals Inc
Publication of AU2001276026A1 publication Critical patent/AU2001276026A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70532—B7 molecules, e.g. CD80, CD86
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001276026A 2000-07-20 2001-07-20 B7-h2 molecules, novel members of the b7 family and uses thereof Abandoned AU2001276026A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/620,461 US6635750B1 (en) 2000-07-20 2000-07-20 B7-H2 nucleic acids, members of the B7 family
US09620461 2000-07-20
PCT/US2001/023094 WO2002008279A2 (en) 2000-07-20 2001-07-20 B7-h2 molecules, novel members of the b7 family and uses thereof

Publications (1)

Publication Number Publication Date
AU2001276026A1 true AU2001276026A1 (en) 2002-02-05

Family

ID=24486045

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001276026A Abandoned AU2001276026A1 (en) 2000-07-20 2001-07-20 B7-h2 molecules, novel members of the b7 family and uses thereof

Country Status (3)

Country Link
US (4) US6635750B1 (en)
AU (1) AU2001276026A1 (en)
WO (1) WO2002008279A2 (en)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7041474B2 (en) * 1998-12-30 2006-05-09 Millennium Pharmaceuticals, Inc. Nucleic acid encoding human tango 509
US20080213778A1 (en) * 1998-12-30 2008-09-04 Millennium Pharmaceuticals, Inc. Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
CN1309734C (en) 1999-02-03 2007-04-11 安姆根有限公司 Polypeptides involved in immune response
US7708993B2 (en) 1999-02-03 2010-05-04 Amgen Inc. Polypeptides involved in immune response
US8624010B1 (en) 1999-02-03 2014-01-07 Steven K. Yoshinaga Nucleic acids encoding B7RP1
AU784634B2 (en) * 1999-11-30 2006-05-18 Mayo Foundation For Medical Education And Research B7-H1, a novel immunoregulatory molecule
US7030219B2 (en) * 2000-04-28 2006-04-18 Johns Hopkins University B7-DC, Dendritic cell co-stimulatory molecules
EP1292619B1 (en) 2000-06-06 2008-02-06 Bristol-Myers Squibb Company B7-related nucleic acids and polypeptides and their uses for immunomodulation
EP1892251A3 (en) * 2000-06-06 2008-12-31 Brystol-Myers Squibb Company B7-related nucleic acids and polypeptides and their uses for immunomodulation
US20030031675A1 (en) 2000-06-06 2003-02-13 Mikesell Glen E. B7-related nucleic acids and polypeptides useful for immunomodulation
EP1320599A2 (en) 2000-06-28 2003-06-25 Genetics Institute, LLC Pd-l2 molecules: pd-1 ligands and uses therefor
US6635750B1 (en) * 2000-07-20 2003-10-21 Millennium Pharmaceuticals, Inc. B7-H2 nucleic acids, members of the B7 family
WO2002022683A1 (en) * 2000-09-12 2002-03-21 Kirin Beer Kabushiki Kaisha Novel dendritic cell wall membrane and use thereof
AU2001291087A1 (en) * 2000-09-20 2002-04-02 Amgen Inc. B7-like molecules and uses thereof
WO2002086083A2 (en) * 2001-04-20 2002-10-31 Mayo Foundation For Medical Education And Research Methods of enhancing cell responsiveness
JP4181032B2 (en) * 2001-05-25 2008-11-12 アムジェン インコーポレーテッド B7-related protein-2 molecule and use thereof
AU2002351505B2 (en) * 2001-10-19 2008-04-03 Genentech, Inc. Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
US7235631B2 (en) * 2002-02-07 2007-06-26 Mayo Foundation For Medical Education And Research ICOS mutants
AU2003238251B2 (en) * 2002-06-17 2009-05-21 Wyeth Inhibition of T cell activation by butyrophilin 4 or B7-L1
US20040102398A1 (en) * 2002-11-23 2004-05-27 Isis Pharmaceuticals Inc. Modulation of B7H expression
JP4488512B2 (en) 2002-06-19 2010-06-23 レイベン バイオテクノロジーズ，インコーポレイティド Novel RAAG10 cell surface target and antibody family that recognizes the target
US7432351B1 (en) 2002-10-04 2008-10-07 Mayo Foundation For Medical Education And Research B7-H1 variants
WO2005044999A2 (en) * 2003-11-05 2005-05-19 New England Medical Center Hospitals, Inc. Treatment with immunoregulatory t cells
AU2005270918B2 (en) 2004-08-03 2011-03-03 Innate Pharma S.A. Therapeutic and diagnostic methods and compositions targeting 4Ig-B7-H3 and its counterpart NK cell receptor
HUE039237T2 (en) 2004-10-06 2018-12-28 Mayo Found Medical Education & Res B7-h1 and pd-1 in treatment of renal cell carcinoma
AU2006254902B8 (en) 2005-06-08 2012-08-16 Dana-Farber Cancer Institute, Inc. Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (PD-1) pathway
US20100015642A1 (en) * 2006-01-05 2010-01-21 Kwon Eugene D B7-h1 and survivin in cancer
WO2007082154A2 (en) * 2006-01-05 2007-07-19 Mayo Foundation For Medical Education And Research B7-h1 and b7-h4 in cancer
WO2007124361A2 (en) * 2006-04-20 2007-11-01 Mayo Foundation For Medical Education And Research Soluble b7-h1
MX351975B (en) * 2006-12-27 2017-11-06 Emory Univ Star COMPOSITIONS and METHODS FOR THE TREATMENT OF INFECTIONS and TUMORS.
EP2170946A2 (en) * 2007-07-13 2010-04-07 The Johns Hopkins University B7-dc variants
US20110020325A1 (en) * 2008-02-29 2011-01-27 Kwon Eugene D Methods for reducing granulomatous inflammation
PL2350129T3 (en) 2008-08-25 2015-12-31 Amplimmune Inc Compositions of pd-1 antagonists and methods of use
CA2735006A1 (en) * 2008-08-25 2010-03-11 Amplimmune, Inc. Pd-1 antagonists and methods of use thereof
JP5686600B2 (en) * 2008-10-22 2015-03-18 株式会社メディネット New monoclonal antibodies and their uses
CA2744449C (en) 2008-11-28 2019-01-29 Emory University Methods for the treatment of infections and tumors
KR20210060670A (en) * 2008-12-09 2021-05-26 제넨테크, 인크. Anti-pd-l1 antibodies and their use to enhance t-cell function
AU2010282340B2 (en) 2009-08-13 2016-12-22 The Johns Hopkins University Methods of modulating immune function
MX2012011688A (en) 2010-04-09 2012-11-23 Amgen Inc Btnl9 proteins, nucleic acids, and antibodies and uses thereof.
US9458246B2 (en) 2013-03-13 2016-10-04 Amgen Inc. Proteins specific for BAFF and B7RP1
JOP20140087B1 (en) 2013-03-13 2021-08-17 Amgen Inc Proteins specific for baff and b7rp1 and uses thereof
US9302005B2 (en) 2013-03-14 2016-04-05 Mayo Foundation For Medical Education And Research Methods and materials for treating cancer
ES2714708T3 (en) 2013-10-01 2019-05-29 Mayo Found Medical Education & Res Procedures for the treatment of cancer in patients with elevated levels of Bim
US10302653B2 (en) 2014-05-22 2019-05-28 Mayo Foundation For Medical Education And Research Distinguishing antagonistic and agonistic anti B7-H1 antibodies
US10517875B2 (en) 2014-07-23 2019-12-31 Mayo Foundation for Medical Engineering and Research Targeting DNA-PKcs and B7-H1 to treat cancer
RS61943B1 (en) 2015-04-17 2021-07-30 Alpine Immune Sciences Inc Immunomodulatory proteins with tunable affinities
MX2017016844A (en) 2015-07-16 2018-08-15 Biokine Therapeutics Ltd Compositions and methods for treating cancer.
WO2017075045A2 (en) 2015-10-30 2017-05-04 Mayo Foundation For Medical Education And Research Antibodies to b7-h1
CN110753755B (en) 2016-03-21 2023-12-29 丹娜法伯癌症研究院 T cell depletion state specific gene expression regulator and application thereof
AU2017250358B2 (en) 2016-04-15 2023-06-01 Alpine Immune Sciences, Inc. ICOS ligand variant immunomodulatory proteins and uses thereof
IL310729A (en) 2016-04-15 2024-04-01 Alpine Immune Sciences Inc Cd80 variant immunomodulatory proteins and uses thereof
WO2018119411A1 (en) * 2016-12-23 2018-06-28 Trustees Of Boston University Classification of diffuse large b-cell lymphoma
WO2018170023A1 (en) 2017-03-16 2018-09-20 Alpine Immune Sciences, Inc. Pd-l2 variant immunomodulatory proteins and uses thereof
JP2020523018A (en) 2017-06-09 2020-08-06 プロビデンス ヘルス アンド サービシーズ−オレゴン Use of CD39 and CD103 for identification of tumor-reactive human T cells for treatment of cancer
CA3078517A1 (en) 2017-10-18 2019-04-25 Alpine Immune Sciences, Inc. Variant icos ligand immunomodulatory proteins and related compositions and methods
CA3218590A1 (en) 2021-06-07 2022-12-15 Providence Health & Services - Oregon Cxcr5, pd-1, and icos expressing tumor reactive cd4 t cells and their use

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6641809B1 (en) 1990-03-26 2003-11-04 Bristol-Myers Squibb Company Method of regulating cellular processes mediated by B7 and CD28
US5851795A (en) 1991-06-27 1998-12-22 Bristol-Myers Squibb Company Soluble CTLA4 molecules and uses thereof
JPH09500788A (en) 1993-07-26 1997-01-28 ダナ・ファーバー・キャンサー・インスティテュート・インコーポレイテッド B7-2: CTLA4 / CD28 counter receptor
US5942607A (en) 1993-07-26 1999-08-24 Dana-Farber Cancer Institute B7-2: a CTLA4/CD28 ligand
US6084067A (en) 1993-07-26 2000-07-04 Dana-Farber Cancer Institute CTLA4/CD28 ligands and uses therefor
US5861310A (en) 1993-11-03 1999-01-19 Dana-Farber Cancer Institute Tumor cells modified to express B7-2 with increased immunogenicity and uses therefor
WO1995005464A1 (en) 1993-08-16 1995-02-23 Arch Development Corporation B7-2: ctla4/cd28 counter receptor
WO1997024447A1 (en) 1996-01-02 1997-07-10 Chiron Corporation Immunostimulation mediated by gene-modified dendritic cells
EP1715043A3 (en) 1998-12-23 2007-01-10 Corixa Corporation Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
AU3899700A (en) 1999-03-17 2000-10-04 Alphagene, Inc. Secreted proteins and polynucleotides encoding them
JP2002543769A (en) 1999-04-02 2002-12-24 コリクサ コーポレイション Compounds and methods for treatment and diagnosis of lung cancer
EP1074617A3 (en) 1999-07-29 2004-04-21 Research Association for Biotechnology Primers for synthesising full-length cDNA and their use
EP1244683A4 (en) 1999-11-12 2005-01-12 Human Genome Sciences Inc 21 human secreted proteins
AU2608201A (en) 1999-12-30 2001-07-16 Corixa Corporation Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
US7030219B2 (en) 2000-04-28 2006-04-18 Johns Hopkins University B7-DC, Dendritic cell co-stimulatory molecules
EP1292619B1 (en) * 2000-06-06 2008-02-06 Bristol-Myers Squibb Company B7-related nucleic acids and polypeptides and their uses for immunomodulation
EP1320599A2 (en) * 2000-06-28 2003-06-25 Genetics Institute, LLC Pd-l2 molecules: pd-1 ligands and uses therefor
US6635750B1 (en) * 2000-07-20 2003-10-21 Millennium Pharmaceuticals, Inc. B7-H2 nucleic acids, members of the B7 family
US6812339B1 (en) * 2000-09-08 2004-11-02 Applera Corporation Polymorphisms in known genes associated with human disease, methods of detection and uses thereof

Also Published As

Publication number Publication date
US7432062B2 (en) 2008-10-07
WO2002008279A2 (en) 2002-01-31
US6630575B2 (en) 2003-10-07
WO2002008279A3 (en) 2002-06-27
US6635750B1 (en) 2003-10-21
US20020106730A1 (en) 2002-08-08
US20040137577A1 (en) 2004-07-15
US20090269783A1 (en) 2009-10-29

Similar Documents

Publication Publication Date Title
AU2001276026A1 (en) B7-h2 molecules, novel members of the b7 family and uses thereof
AU2002315389A1 (en) Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
AU2001283507A1 (en) B7-h3 and b7-h4, novel immunoregulatory molecules
AU2001249423A1 (en) 38692 and 21117, novel dual specificity phosphatase molecules and uses therefor
AU2001247788A1 (en) 32142, 21481, 25964, 21686, novel human dehydrogenase molecules and uses therefor
AUPQ339899A0 (en) Novel molecules
AU2002315388A1 (en) Novel phenylamino-pyrimidines and uses thereof
AU2002245332A1 (en) Anergy-regulated molecules
AU2002368044A1 (en) Co-stimulatory molecules
AU2002330074A1 (en) Tall-1 receptor molecules and uses thereof
AU2002337312A1 (en) Molecules
AU2001275990A1 (en) 16816 and 16839, novel human phospholipase c molecules and uses therefor
AU2002362414A1 (en) Novel molecules of the hkid-1-related protein family and uses thereof
AU3512900A (en) Novel thioredoxin family active site molecules and uses therefor
AU2002257430A1 (en) Androgen-mediated neuroprotection and uses thereof
AU2001291235A1 (en) 22108 and 47916, novel human thioredoxin family members and uses thereof
AU2002363761A1 (en) Porus materials based on template-forming microorganisms
AU2001253386A1 (en) Haplotypes of the impdh2 gene
AU2001288423A1 (en) Haplotypes of the bmpr2 gene
AU2001253101A1 (en) Haplotypes of the scn2b gene
AUPR849001A0 (en) Immunointeractive molecules and uses thereof
AU2002246541A1 (en) Rna polymers and uses thereof
AU2001295337A1 (en) E. histolytica-specific antibodies and clinical uses thereof
AU2016202471A1 (en) Molecules with extended half-lives, compositions and uses thereof
AUPR713201A0 (en) Novel therapeutic molecules and uses therefor